| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| April 23, 2026 | ±2.8% | -3.1% | under-priced |
| October 23, 2025 | ±2.5% | +1.4% | over-priced |
| July 24, 2025 | ±2.5% | +1.0% | over-priced |
| April 23, 2025 | ±3.4% | +0.2% | over-priced |
| October 23, 2024 | ±2.1% | +0.2% | over-priced |
| July 24, 2024 | ±2.4% | -4.0% | under-priced |
| May 2, 2024 | ±1.9% | +0.9% | over-priced |
| October 26, 2023 | ±2.8% | -1.3% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2026 | $3.73 | $2.1B | $661M |
| Q4 FY2025 | $3.41 | $1.9B | $611M |
| Q3 FY2025 | $3.60 | $2.0B | $647M |
| Q2 FY2025 | $3.21 | $1.9B | $579M |
Moody's Corporation (MCO) reports in 85 days, with the next report estimated for September 6, 2026. Across the last 8 reports, options priced an average ±2.5% earnings move while the stock actually moved 1.5% on average — the market has systematically over-priced MCO's earnings risk. Fundamentals into the print: EPS up 7.8% year-over-year, revenue up 8.1%. QuantLogix's live 5-factor engine currently reads MCO as a buy at 56/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →